Roscovitine

Roscovitine__p34/cdc2 inhibitor Verubecestat

Product Name Roscovitine
Description

p34/cdc2 inhibitor

Purity >95% (HPLC, TLC)
CAS No. 186692-46-6
Molecular Formula C19H26N6O
Molecular Weight 354.4
Storage Temperature -20ºC
Shipping Temperature Shipped Ambient
Product Type Inhibitor
Solubility Soluble in DMSO
Source Synthetic
Appearance White to off-white solid
SMILES email protected(NC2=NC1=C(N=CN1C(C)C)C(=N2)NCC3=CC=CC=C3)(CO)CC
InChI InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1
InChIKey BTIHMVBBUGXLCJ-OAHLLOKOSA-N
Safety Phrases Classification:
Not a hazardous substance or mixture.

Safety Phrases:
S22 – Do not breathe dust.
S24/25 – Avoid contact with skin and eyes.
S36/37/39 – Wear suitable protective clothing, gloves and eye/face protection.

Cite This Product Roscovitine (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-472)
Alternative Names 2-(R)-9-(1-Methylethyl)-6-(phenylmethyl)amino-9H-purin-2-ylamino-1-butanol, 6-Benzylamino-2-(R)-(1-ethyl)-2-hydroxyethylamino-9-isopropylpurine, 2(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine
Research Areas Cell Signaling
PubChem ID 160355
Scientific Background Roscovitine is a potent and selective inhibitor of cyclin-dependent kinases (CDKs). It is specifically selective for CDK1/cyclin B kinase, CDK2 and CDK5/p35. It inhibits M phase promoting factor kinase activity and affects calcium channel gating.
References 1. De Azevedo, et al. (1997) Eur. J. Biochem. 243(1-2): 518–526.